Con la colaboración de

Programa

08:45

Welcome

Anna Bigas Salvans. Scientific Director of CIBERONC

Amparo Cano García & Gema Moreno Bueno. Training and Mobility Programme Coordinator

Ver sesión

09:00

Respiratory Tract Tumours Research Programme

Chair: Eva Mª Verdugo Sivianes

Ver sesión
The phosphatidylinositol transfer protein PITPNC1, functional role and clinical implications in mutant KRAS lung adenocarcinoma.

Rodrigo Entrialgo Cadierno. Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Luis Montuenga Group.

Ver sesión
Integration of drug repurposing and combinatorial screening identifies novel therapies in mutant KRAS lung cancer.

Irati Macaya Erro. Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Luis Montuenga Group.

Ver sesión

09:30

Breast Cancer Research Programme

Chair:Manuel Gámez Chiachio

Ver sesión
Oncofoetal gene SALL4: a potential marker for Trastuzumab resistance HER2+ Breast Cancer.

Birlipta Pattanayak.Instituto de Investigación Sanitaria INCLIVA. Ana Lluch Group.

Ver sesión
JAK2 downmodulation leads to interferon gamma deficient response and resistance to immunotherapy in breast cancer.

Enrique Javier Arenas Lahuerta.Vall d’Hebron Instituto de Oncología (VHIO). Joaquín Arribas Group.

Ver sesión

10:00

Round Table: Women in science

Chairs: Claudia Coscia Requena & Sandra Díez Villares

María Salazar Roa.Group Leader at Universidad Complutense Madrid and CNIO, Spain.

Marisol Soengas González.Group Leader at CNIO.

Marta Macho Stadler.Group Leader at Universidad del País Vasco, Spain and Science Communicator.

Núria Salán Ballesteros.Professor at UPC, Spain, president of SCT and Science Communicator.

Ver sesión

11:00

Break

11:15

Gastrointestinal Tumours Research Programme

Chair: Claudia Coscia Requena

Ver sesión
Preliminary evaluation of highly sensitive assessment of microsatellite instability as a tool for cancer risk individualization in Lynch syndrome.

Júlia Canet Hermida.Instituto de Investigación Biomédica de Bellvitge. Gabriel Capellà Group.

Ver sesión
Landscape of tumor infiltrating B and T cell repertoire in pancreatic cancer.

Silvia Pineda San Juan.Centro Nacional de Investigaciones Oncológicas (CNIO). Núria Malats Group.

Ver sesión

11:45

Poster session

Chair: Noelia Dasilva Freire

Ver sesión

12:30

Round Table: Mental health during PhD

Chairs: Manuel Gámez Chiachio & Pilar Bustamante Madrid

Fernando T. Maestre Gil.Group Leader at Universidad de Alicante, Spain.

Miguel Ángel Sorrel Luján.Assistant Professor at Universidad Autónoma de Madrid, Spain.

Yorick Peterse.Biomedical and Mental Health Scientist.

Ver sesión

13:30

Closing remarks

Chair: Sandra Díez Villares

Ver sesión

8:55

Welcome
Ver sesión

09:00

Haematological Tumours Research Programme

Chair: Noelia Dasilva Freire

Ver sesión
Immunologic characterization of Coronavirus Disease 2019 (COVID-19) patients with hematological cancer: biologic and clinical signicance.

Catarina Alexandra Da Silva Maia. Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Jesús San Miguel Group.

Ver sesión
Mutational profile and Copy Number Alterations of Follicular Lymphoma patients with different clinical behavior

Cristina López González. Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS). Elías Campo Group.

Ver sesión

09:30

Low Prevalence Tumours Research Programme

Chair: Sandra Díez Villares

Ver sesión
Study of ARID1A context-dependent functions in endometrial cancer.

Cristina Megino Luque. Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré (IRBLleida). Xavier Matías-Guiu Group.

Ver sesión
Analysis of NAB2- STAT6 gene fusion in 87 cases of Solitary Fibrous Tumor: concordance molecular-testing study and novel STAT6 fusion partners.

Carmen Salguero Aranda.Instituto de Biomedicina de Sevilla (IBIS). Enrique de Álava Group.

Ver sesión

10:00

Mechanisms of Tumour Progression Research Programme

Chair: Pilar Bustamante Madrid

Ver sesión
Development of CAR-DOT cells for allogeneic cancer immunotherapy of AML.

Néstor Tirado Cabrera. Instituto de Investigación contra la Leucemia Josep Carreras (IJC). Anna Bigas Group.

Ver sesión
Luzp1 is a novel regulator of cell division, migration and invasion through the actin cytoskeleton.

Laura Bozal Basterra. Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE). Arkaitz Carracedo Group.

Ver sesión

10:30

Break

10:45

Plenary Lecture

Chair: Amparo García Cano

Targeting KRAS mutant cancers: an urgent medical need.

Professor Mariano Barbacid

Ver sesión

11:30

Poster session

Chair: Claudia Coscia Requena

Ver sesión

12:15

Round Table: Future perspectives after PhD

Chairs: Eva Mª Verdugo Sivianes & Noelia Dasilva Freire.

Ángela Bernardo Álvarez.Science Journalist at Fundación Ciudadana Civio.

Antonio Lucena Cacace. Postdoctoral Researcher at Center for iPS Cell Research and Application (CiRA), Japan.

Clara León Annicchiarico. Medical Science Liaison Immunology at Sanofi Genzyme, Spain.

Ver sesión

13:15

Challenge

Contest with some questions about the oral communications open to everyone with some prizes as a reward.


Chair: Manuel Gámez Chiachio

Ver sesión

13:45

Awards & Closing Ceremony

Chair: Pilar Bustamante Madrid & Eva Mª Verdugo Sivianes

Ver sesión

14:15

Tribute to Amparo Cano
Ver sesión

14:30

Closure
Ver sesión